Clinical Trials Logo

Clinical Trial Summary

This non-controlled multicentre phase II study is designed to assess the safety and to describe (in relation to children of higher age) the pharmacodynamics of recombinant ASNase (rASNase) for first-line treatment of infants (< 1 year of age at diagnosis) with de novo acute lymphoblastic leukaemia


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00983138
Study type Interventional
Source medac GmbH
Contact
Status Completed
Phase Phase 2
Start date July 2009
Completion date February 2011

See also
  Status Clinical Trial Phase
Recruiting NCT05959720 - Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil
Recruiting NCT02933333 - G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor Phase 4
Completed NCT02953730 - The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents Phase 4
Completed NCT02767388 - Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
Recruiting NCT03610438 - Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia Phase 2
Recruiting NCT05792007 - Study of the Medullary Microenvironment in Acute Childhood Leukemia N/A
Completed NCT02294552 - Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT Phase 2
Completed NCT01461538 - Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies Phase 2
Recruiting NCT04167683 - Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
Recruiting NCT05150561 - Muscle Dysfunction in Patients With Haematological Diseases
Active, not recruiting NCT04669210 - PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT Phase 2
Active, not recruiting NCT04013685 - Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies Phase 1
Recruiting NCT02345915 - Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia N/A
Completed NCT01720264 - Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant Phase 2
Not yet recruiting NCT02413021 - The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens Phase 1
Not yet recruiting NCT06427330 - Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia Phase 2
Active, not recruiting NCT04778579 - Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy Phase 2
Recruiting NCT03448393 - CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies Phase 1
Completed NCT03833180 - A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) Phase 1
Active, not recruiting NCT03367299 - Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia Phase 2